drugset / Trial / NCT02721511

A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen

NCT02721511

NaSingle-groupOpen-labelTreatment

Summary

This is a, prospective, single center, open-label, pilot study to evaluate the safety and efficacy of the subcutaneous administration of a novel furosemide formulation. The results of this pilot study will be reviewed to determine the safety of the subcutaneous treatment regimen and to evaluate patient selection criteria for possible at home treatment. The intent is to conduct a future follow on study looking at the feasibility of at home treatment of patients referred to a hospital for treatment of fluid overload.

Timeline

Start
2016-05
Primary completion
2017-03-07
Completion
2017-03-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 80 mg Subcutaneous

Indications